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Abstract
Introduction: Studies have been conducted to investigate the association between rs10830963 of MTNR1B and the risk of gestational 
diabetes mellitus (GDM), but with inconclusive results. We aimed to clarify these controversies, especially with regard to the association 
in the Chinese population. 
Material and methods: A systemic literature reference search inclusive to August 12, 2016 yielded 35 articles, from which 11 studies met 
the inclusion criteria for the final meta-analysis, including 3889 patients with GDM and 6708 controls. 
Results: We found statistically significant associations between rs10830963 and GDM using odds ratios (ORs) and 95% confidence intervals 
(CIs) [GG genotype vs. CC genotype: OR = 1.70, 95% CI: 1.38–2.10; G allele vs C allele: OR = 1.27, 95% CI: 1.20–1.36; GG+CG vs. CC 
(dominant model): OR = 1.31, 95% CI: 1.20–1.44; GG vs CG+CC (recessive model): OR = 1.41, 95% CI: 1.26–1.58]. In subgroup analyses 
stratified by ethnicity, we also observed rs10830963 to be associated with significantly increased risk of GDM in all genetic models in the 
Chinese population. 
Conclusions: Our meta-analysis indicated that the rs10830963 polymorphism might serve as a risk factor of GDM in the Chinese popula-
tion. (Endokrynol Pol 2017; 68 (5): 550–560)
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Streszczenie
Wstęp: Wyniki dotychczas badań przeprowadzonych w celu ustalenia związku między polimorfizmem rs10830963 w genie MTNR1B 
a ryzykiem cukrzycy ciążowej (gestational diabetes mellitus, GDM) nie pozwoliły na sformułowanie jednoznacznych wniosków. Niniejsze 
badanie przeprowadzono w celu wyjaśnienia tych kontrowersji, zwłaszcza w odniesieniu do występowania tych związków w populacji 
chińskiej.
Materiał i metody: W wyniku przeszukania w sposób systematyczny piśmiennictwa obejmującego okres do 12 sierpnia 2016 roku wy-
typowano 35 artykułów, spośród których 11 badań spełniało kryteria włączenia do metaanalizy. Obejmowały one 3889 chorych z GDM 
i 6708 osób kontrolnych.
Wyniki: Autorzy stwierdzili statystycznie istotny związek między polimorfizmem rs10830963 a GDM, obliczając ilorazy szans (odds ratio, 
OR) i 95-procentowe przedziały ufności (confidence interval, CI) [genotyp GG vs. genotyp CC: OR = 1,70; 95% CI: 1,38–2,10; allel G vs. allel 
C: OR = 1,27; 95% CI: 1,20–1,36; GG+CG vs CC (model dominujący): OR = 1,31; 95% CI: 1,20–1,44; GG vs. CG+CC (model recesywny): 
OR = 1,41; 95% CI: 1,26–1,58]. W analizach podgrup wydzielonych na podstawie pochodzenia etnicznego również stwierdzono, że 
polimorfizm rs10830963 wiąże się z istotnie wyższym ryzykiem GDM we wszystkich modelach genetycznych w populacji chińskiej.
Wnioski: Przeprowadzona przez autorów metaanaliza wskazuje, że polimorfizm rs10830963 może być uważany za czynnik ryzyka GDM 
w populacji chińskiej. (Endokrynol Pol 2017; 68 (5): 550–560)
Słowa kluczowe: polimorfizm pojedynczego nukleotydu, gen receptora melatoniny 1B, cukrzyca ciążowa, metaanaliza
Introduction
Gestational diabetes mellitus (GDM), defined as glucose 
intolerance of variable degree with onset or first recog-
nition during pregnancy, is among the most common 
metabolic disorders during pregnancy. The prevalence 
of GDM, with a rising trend globally, varies by area and 
ethnic population. During the last decade, the preva-
lence of GDM among western countries varied from 
1–3% to 8–18% [1, 2]. For Asian females, including the 
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Chinese Han population, the prevalence of GDM was 
hypothesised to be higher than in Caucasian females [3]. 
Studies have shown that GDM is strongly associated 
with both maternal and offspring adverse health out-
comes, including macrosomia, stillbirths, and neonatal 
metabolic disturbances. Pregnant women with GDM 
are more likely to be affected with type 2 diabetes mel-
litus (T2DM) and develop multiple cancers in the years 
following pregnancy [4]. With the increasing incidence 
and severe consequence of GDM, it has become a grow-
ing health concern. 
GDM, caused by environmental and genetic factors, 
as well as gene-environment interactions, shares similar 
pathophysiological features to T2DM, such as glucose 
intolerance, insulin resistance, and impaired pancreatic 
β-cell function [5–7]. Furthermore, several studies have 
revealed that women with GDM history are more likely 
to develop T2DM. In addition, women with a family 
history of T2DM may be more predisposed to develop 
GDM than those without a GDM history [1, 6]. These 
studies suggest that susceptible genes are involved 
in T2DM and probably also contribute to the genetic 
aetiology of GDM.
Table I. Characteristics of included studies
Tabela I. Charakterystyka włączonych badań
Author Year Ethnicity GDM Control Diagnostic 
criteria
Genotyping 
methodSample 
size
Age 
mean ± SD
Pregravid BMI 
mean ± SD
Sample 
size
Age 
mean ± SD
Pregravid BMI 
mean ± SD
Deng 2011 Chinese 87 31.8 ± 4.6 23.6 ± 3.0 91 29.7 ± 3.5 21.5 ± 2.4 OGTT 
confirmed
Sequencing
Wang 2011 Chinese 725 30.00 
(28.00, 3.00)*
21.48 
(19.57, 23.62)*
1039 32.00 
(30.00, 35.00)*
21.72 
(19.89, 24.04)
GDM per ADA 
criteria
TaqMan
Kim 2011 Korean 928 33.17 
(22–52)*
23.32 ± 4.01 990 32.24 
(23–44)*
21.40 ± 2.93 OGTT 
confirmed
TaqMan
Vlassi 2012 Greek 77 35.45 ± 4.44 25.83 ± 5.13 98 31.39 ± 5.25 26.76 ± 6.26 GDM per ADA 
criteria
Applied 
Biosystems 
SNaPshot
Qi 2013 Chinese 110 28.75 ± 3.19 NA 110 28.17 ± 2.43 NA GDM per ADA 
criteria
PCR-SSCP
Li 2013 Chinese 350 32.42 ± 4.87 25.34 ± 5.27 480 31.98 ± 5.21 24.69 ± 4.61 GDM per 
IADPSG 
criteria
PCR-RFLP
Stuebe 2014 Caucasian 56 NA NA 843 NA NA OGTT 
confirmed
Sequenom 
iPLEX platform
African- 
American
24 NA NA 362 NA NA OGTT 
confirmed
Sequenom 
iPLEX platform
Wang 2014 Chinese 184 28.2 ± 3.8 21.2 ± 1.8 235 27.9 ± 4.1 20.7 ± 1.4 OGTT 
confirmed
PCR-SSCP
Vejrazkova 2014 Czechs 485 34.1 ± 6.12 24.3 ± 4.93 422 34.8 ± 15.09 23.7 ± 4.18 WHO 
guidelines
TaqMan
Junior 2015 Euro-
Brazilian
183 32 
(28–36)*
32.0 
(27.7–36.4)*
183 29  
(27–33)*
25.4 
(22.5–28.3)*
GDM per ADA 
criteria
TaqMan
Liu 2016 Chinese 674 31.6# 24.41# 690 32.1 25.12 OGTT 
confirmed
TaqMan
*The results are presented as median (interquartile-range); # The results are presented as mean only; OGTT, the oral glucose tolerance test; ADA, the American 
Diabetes Association; IADPSG, the International Association of Diabetes in Pregnancy Study Groups
Figure 1. Flow diagram of the selected studies and specific reasons 
for exclusion from the present meta-analysis
Rycina. 1. Diagram przedstawiający wybór badań i przyczyny 
wykluczenia niektórych badań z metaanalizy
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Melatonin receptor 1B (MTNR1B) gene, as a novel 
diabetogenic gene, is located on human chromosome 
11q21–22 [8–11] and encodes MTNR1B protein, 
which belongs to the G protein-coupled receptor 
family and plays an inhibitory role in insulin secre-
tion [12]. Knockout mice of MTNR1B were found 
to have significantly decreased fasting glucose 
levels [13]. 
Recently, considerable efforts have been devoted 
to exploring the relationships between the MTNR1B 
polymorphisms and GDM. Among them, rs10830963, 
an intron SNP of MTNR1B, has been studied in depth. 
Because there is controversy among previous studies 
over the association between the rs10830963 poly-
morphism and the incidence of GDM and the lack of 
sufficient evidence about this variation on GDM, we 
performed a meta-analysis to explore the association 
between the rs10830963 polymorphism in the MTNR1B 
gene and GDM risk around the world, especially in 
the Chinese Han population.
Material and methods
Literature search strategy
We conducted a systemic search on PubMed, Embase, 
and China National Knowledge Infrastructure (CNKI) 
databases up to August 12, 2016 using the following 
keywords: (1) “Melatonin receptor 1B” or “MTNR1B”; (2) 
“gestational diabetes mellitus” or “GDM” or “pregnancy 
diabetes mellitus”; and (3) “polymorphism” or “variant” 
or “genotype”. The literature search was restricted to 
studies published in English or Chinese. In addition, all 
references of articles retrieved were hand-searched for 
additional articles relevant to this topic. For articles by 
the same author using the same case series, we selected 
the study with the largest sample size.
Figure 2. Forest plots of the association between the rs10830963 polymorphism in MTNR1B and risk of GDM in the homozygote GG 
genotype comparison
Rycina 2. Wykresy typu forest plot przedstawiające związek między polimorfizmem rs10830963 w genie MTNR1B a ryzykiem GDM 
w porównaniu homozygot GG
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Eligible studies and data extraction
Eligible studies had to meet the following criteria: 
(1) original papers containing independent data, 
(2) all patients met the diagnostic criteria for GDM, 
(3) papers were case–control studies, (4) investiga-
tions evaluated the relationship between rs10830963 
and GDM susceptibility, and (5) sufficient available 
published data for odds ratio (OR) estimation with 
95% confidence interval (CI) and P-value. The major 
reasons for excluding studies were: (1) overlapping 
data, (2) design other than a case-control study, and 
(3) no available data reported.
Two reviewers (Lu and Wu) blindly performed data 
extraction separately for all selected publications. For each 
of the included articles, we extracted the first author’s 
name, publication year, study population (ethnicity), 
definition and numbers of cases and controls, mean age 
of cases and controls, body mass index (BMI), frequency 
of genotypes, Hardy-Weinberg equilibrium status, and 
genotyping method. For studies that included subjects 
of different ethnic groups, we extracted data for each 
one. Further discussion among all authors resolved any 
disagreement by consensus on a given extracted item.
Statistical methods
Summary statistics were performed with Review 
Manager 5.1 software (RevMan 5.1. Copenhagen: The 
Nordic Cochrane Centre, the Cochrane Collabora-
tion, 2011). Calculating OR and 95% CI measured 
the strength of association between polymorphism 
rs10830963 and GDM risk. The statistical significance 
of the pooled OR was determined with the Z-test. 
The pooled ORs and 95% CIs were calculated, respec-
tively, by comparisons between the GDM group and 
control group using the following genetic models: 
(1) allelic model (G vs. C); (2) additive model (GG vs. CC); 
(3) dominant model (GG+GC vs. CC); and (4) recessive 
model (GG vs. GC+CC). For each genetic comparison, 
Figure 3. Forest plots of the association between the rs10830963 polymorphism in MTNR1B and risk of GDM in the allele comparison
Rycina 3. Wykresy typu forest plot przedstawiające związek między polimorfizmem rs10830963 w genie MTNR1B a ryzykiem GDM 
w porównaniu alleli
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subgroup analysis according to background ethnicity 
was carried out in the Chinese to estimate the ethnic-
specific OR.
For evaluating possible heterogeneity across 
the studies, a statistical test for heterogeneity was 
performed by a Chi-square-based Q-test. Statisti-
cal heterogeneity was assessed by I2 measurement. 
A random-effect model was adopted when the ef-
fects were assumed to be homogenous (I2 > 50% and 
p < 0.05). Otherwise, a fixed-effect model was adopt-
ed [14]. Two-sided P value less than 0.05 was considered 
statistically significant.
Results
Characteristics of included studies
We initially identified 35 eligible references. Among 
these, we excluded 24 studies because of unmatched 
search criteria, such as not a case-control study, other 
loci besides rs10830963, or overlapping publications. 
Finally, 11 studies with 3889 GDM cases and 6708 
controls were included in the meta-analysis, and half 
of the articles focused on the association in the Chinese 
population [15–25]. Figure 1 shows details of the study 
selection process.
Association of MTNR1B rs10830963 Polymor-
phism with GDM
As shown in Figure 2, the heterogeneities for the overall 
data are small, and p values were all greater than 0.05 in 
all comparisons except for the GG genotype (I2 = 51%, 
p = 0.02). Moreover, according to the stratified analysis 
of ethnicity, we found that the heterogeneities in the 
Chinese population subgroup were all small and that 
there was no significant heterogeneity for any model 
comparison. This suggests that ethnicity may be a sub-
stantial factor contributing to heterogeneity. According 
to the heterogeneity for comparisons of each model in 
the overall analysis, we adopted a random-effect model 
to analyse the GG genotype comparison model. Other 
comparisons without heterogeneities were analysed 
using the fixed-effect model.
Figure 4. Forest plots of the association between the rs10830963 polymorphism in MTNR1B and risk of GDM in the dominant genetic 
model comparison
Rycina 4. Wykresy typu forest plot przedstawiające związek między polimorfizmem rs10830963 w genie MTNR1B a ryzykiem GDM 
w porównaniu dominujących modeli genetycznych
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In general, we observed positive evidence of notable 
associations between the increased risk of GDM and the 
variant in multiple genetic models when all the eligi-
ble studies were pooled into the meta-analysis. Using 
the fixed effect model, the pooled OR of the G allele 
was 1.27 (95% CI = 1.20–1.36, p < 0.00001, Figure 3), 
and the corresponding results of the dominant and 
recessive genetic models were 1.31 (95% CI = 1.20–1.44, 
p < 0.00001, Figure 4) and 1.41 (95% CI = 1.26–1.58, 
p < 0.00001, Figure 5), respectively. Therefore, because 
of the significant heterogeneity, the association for the 
GG genotype on GDM was analysed using the random 
effect model, and the pooled OR value was 1.70 (95% 
CI = 1.38–2.10, p < 0.00001, Figure 2). In addition, the 
association between heterozygote CG genotype and 
GDM was statistically significant, with the pooled OR 
being 1.20 (95% CI = 1.09–1.33, p = 0.0003, Figure 6).
According to the stratified overall analysis of 
ethnicity, the Chinese were associated with GDM 
susceptibility in all genetic models except for the 
heterozygote CG genotype comparison. To test and 
verify these significant associations in the Chinese 
population, we excluded the participants from the 
Wang (2011) project [18], who weighed the most in 
each meta-analysis. After the exclusion, we reassessed 
the meta-analyses. The results remained significant 
with pooled OR of 1.62, 1.25, 1.20, and 1.42 for the ho-
mozygote genotype, allele, dominant genetic model, 
and recessive genetic model comparisons, respectively 
(Supplementary Figure 1).
Publication bias
We explored publication bias using funnel plots (Figure 7). 
The shapes of the funnel plots did not reveal any evi-
dence of obvious visual asymmetry.
Discussion
It is widely believed that GDM shares similar risk factors 
with T2DM, and women with a GDM history tend to 
Figure 5. Forest plots of the association between the rs10830963 polymorphism in MTNR1B and risk of GDM in the recessive genetic 
model comparison
Rycina 5. Wykresy typu forest plot przedstawiające związek między polimorfizmem rs10830963 w genie MTNR1B a ryzykiem GDM 
w porównaniu recesywnych modeli genetycznych
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have an increased risk of T2DM [1, 26]. We conducted 
a meta-analysis to investigate the potential association 
between the rs10830963 polymorphism in MTNR1B, 
a genetic variant of a known T2DM loci, and GDM risk. 
Our results confirmed significant associations of GDM 
with the rs10830963 polymorphism in the overall popu-
lation, and especially in the Chinese population. To the 
best of our knowledge, this study is the first meta-analysis 
to assess the relationship between the rs10830963 poly-
morphism and GDM susceptibility in Chinese people. 
Despite accumulating evidence recognising mul-
tiple risk factors of GDM, the causes underlying the 
development and progression of GDM have not been 
fully elucidated. GDM only affects a small proportion of 
pregnant women, although pregnancy is characterised 
by progressive insulin resistance and is prone to abnor-
mal glucose tolerance [27, 28]. Normally, the elevated 
insulin secretion by pancreatic islet β-cells compensates 
for elevated insulin resistance, but GDM could develop 
when a genetic predisposition of pancreatic islet β-cell 
impairment is unmasked by increased insulin resistance 
during pregnancy [27, 29]. Several studies using the 
genome-wide association study (GWAS), a powerful 
method for the detection of genetic contributions to 
polygenic diseases, suggest that inherited abnormali-
ties of certain genes related to pancreatic islet β-cell 
function, including MTNR1B, are probably implicated 
in the aetiology of GDM [10, 30].
However, because GWAS has been shown to pro-
duce false associations [31], other types of association 
studies are a useful tool to identify genetic factors 
conferring susceptibility to diseases. A few genetic 
association studies have been conducted in various 
populations to assess possible associations of GDM 
with the genetic variation of rs10830963. Because origi-
nal genetic association studies are generally believed 
to have shortcomings, such as inadequate statistical 
power, population stratification, and publication bias, 
we conducted the current meta-analysis to obtain 
a more comprehensive and intrinsic result of the re-
lationship between the polymorphism of this loci and 
GDM risk.
The strength of the present study is the systematic 
way in which we have summarised results of the 
Figure 6. Forest plots of the association between the rs10830963 polymorphism in MTNR1B and risk of GDM in the heterozygote GC 
genotype comparison
Rycina 6. Wykresy typu forest plot przedstawiające związek między polimorfizmem rs10830963 w genie MTNR1B a ryzykiem GDM 
w porównaniu heterozygot GC
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eligible studies for the SNP–GDM association. Our 
results indicate that the rs10830963 polymorphism 
of MTNR1B is a risk factor for GDM, and we found 
significant associations in all genetic models includ-
ing the heterozygote CG genotype comparison. Our 
conclusion is consistent with former meta-analyses 
by Liu and Zhang [25, 32]. Regarding the population 
that mainly contributes to the between-study hetero-
geneity, we performed stratified analyses by ethnic-
ity to evaluate the heterogeneity between studies. 
Consistent with the results in the overall population, 
we observed significant associations for the polymor-
phism in almost all genetic models in the Chinese 
population. Our results confirmed the earlier finding 
of a positive association in several studies, with the ex-
ception of the study by Wang et al. [18]. The difference 
in Wang’s study could be accounted for by various 
degrees of clinical heterogeneity, which are induced 
by the different severities of GDM, comorbidities, and 
functional status of patients. It should also be noted 
that consensus of the diagnostic criteria of the current 
GDM definition differed in the included studies.
In addition, our results of the overall population 
differed from the Chinese population, which showed 
no significant association of heterozygote CG genotype 
frequency of the rs10830963 polymorphism with GDM 
risk in the Chinese population. The difference may be 
due to the relatively small number of participants. Only 
six studies were included in the Chinese meta-analysis. 
Therefore, additional studies are warranted to further 
validate ethnic differences of the effect of this polymor-
phism on GDM risk.
MTNR1A and MTNR1B, both high-affinity receptors 
of melatonin, are expressed in α-cells and β-cells of the 
Figure 7. Funnel plots for all comparisons in the Chinese population. The shapes of the funnel plots did not reveal any evidence of 
obvious visual asymmetry. SE — standard error; OR — odds ratio
Rycina 7 Wykresy lejkowe dla wszystkich porównań w populacji chińskiej. Kształt wykresów lejkowych nie wykazuje żadnych widocznych 
cech asymetrii. SE — błąd standardowy; OR — iloraz szans
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Supplementary Figure 1. Meta-analyses in Chinese without the Wang 2011 project
Rycina dodatkowa 1. Metaanaliza populacji chińskiej z pominięciem projektu badawczego Wanga z 2011 r.
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pancreatic islets, respectively [33]. The GWAS method 
has recently shown that the MTNR1B/MT2 receptor 
may be involved in the pathogenesis of type 2 dia-
betes mellitus. MTNR1B down-regulates glucokinase 
expression and glucose-stimulated insulin secretion. 
An increased expression of MTNR1B on β-cells leads 
to impaired insulin secretion. Regarding this evidence, 
and comparing with MTNR1A, we suggest that aberrant 
MTNR1B expression is involved in the pathogenesis of 
GDM. Although rs10830963 SNP is in the intron of the 
MTNR1B gene, the significant association found for this 
SNP with GDM suggests that the variation plays a key 
role in the regulation of MTNR1B expression. Previous 
studies have shown that the G allele of rs10830963 poly-
morphism in the MTNR1B exhibits a higher expression 
of this melatonin receptor on the β-cells as compared 
with that of the C allele. Further studies are required 
to confirm this association. 
Some limitations of this study should be addressed, 
to understand the results. First, the small sample size 
of subgroup analysis may not have enough statistical 
power, so further studies with a larger sample size of 
target ethnic groups are required. Second, publication 
bias is a concern in all meta-analyses. Negative studies 
are less likely to be published or are underreported in 
published articles, potentially leading to an overestima-
tion of the association. Finally, the integral outcomes 
were originated in individually unadjusted ORs, while 
models should be adjusted by potentially confounding 
factors, including age, nutritional status, and environ-
mental factors.
Conclusions
This study confirms the association of rs10830963 in MT-
NR1B with GDM risk. Our results suggest that the varia-
tion might increase the incidence of GDM, especially in 
the Chinese population. Our study provides important 
clues on the aetiology of GDM, although further stud-
ies focusing on the affected pathway are still required.
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